M. Jadersten : rechercher sur Z-Library

Année:

2005

Langue:

english

Fichier:

PDF, 80 KB

english, 2005

C023 Expression profiling of CD34+ cells in patients with myelodysplastic syndromes: differences between early and advanced cases and analysis of apoptosis-related genes

A. Pellagatti, M. Cazzola, A. Giagounidis, L. Malcovati, M.G. Della Porta, M. Jädersten, S. Killick, C. Fidler, H. Cattan, D. Bowen, C. Aul, E. Hellström-Lindberg, J.S. Wainscoat, J. Boultwood

Journal:

Année:

2007

Langue:

english

Fichier:

PDF, 52 KB

english, 2007

P136 Treatment with erythropoietin and G-CSF improves survival in MDS patients with low transfusion need

M. Jädersten, L. Malcovati, I. Dybedal, M.G. Della Porta, R. Invernizzi, S.M. Montgomery, C. Pascutto, A. Porwit-MacDonald, M. Cazzola, E. Hellström-Lindberg

Journal:

Année:

2007

Langue:

english

Fichier:

PDF, 166 KB

english, 2007

C014 Expression of p53 or cytoplasmic nucleophosmine associated with increased risk of disease progression in myelodysplastic syndrome with isolated del(5q)

M. Jadersten, L. Saft, H. Garelius, R. Hast, L. Nilsson, J. Samuelsson, A. Porwit, E. Hellström-Lindberg

Journal:

Année:

2009

Langue:

english

Fichier:

PDF, 65 KB

english, 2009

C028 Lenalidomide abrogates the clonal advantage of del(5q) MDS stem cells via alteration of niche interactions

C. Scharenberg, M. Jadersten, J. Palmquist, L. Forsblom, M. Jansson, E. Hellström-Lindberg

Journal:

Année:

2009

Langue:

english

Fichier:

PDF, 46 KB

english, 2009

18 Prognostic impact of TP53 mutations in MDS with del(5q)

M. Jadersten

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 50 KB

english, 2011

19 Debate: Lenalidomide is the standard of care for the management of isolated del 5(q) MDS

M. Jadersten

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 64 KB

english, 2011

259 The clonal advantage of del(5q) MDS stem cells is mediated by increased adhesion to the microenvironment

C. Scharenberg, V. Giai, M. Jädersten, L. Forsblom, M. Jansson, E. Hellström-Lindberg

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 76 KB

english, 2011

Gene expression profiling of CD34+ cells in patients with the 5q− syndrome

Jacqueline Boultwood, Andrea Pellagatti, Helen Cattan, Charles H. Lawrie, Aristoteles Giagounidis, Luca Malcovati, Matteo G. Della Porta, Martin Jädersten, Sally Killick, Carrie Fidler, Mario Cazzola,

Journal:

Andrea Pellagatti, Eva Hellström-Lindberg, Aristoteles Giagounidis, Janet Perry, Luca Malcovati, Matteo G. Della Porta, Martin Jädersten, Sally Killick, Carrie Fidler, Mario Cazzola, James S. Wainscoa

Année:

2007

Langue:

english

Fichier:

PDF, 521 KB

english, 2007

Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal- and translation-related genes

Journal:

Andrea Pellagatti, Teresa Marafioti, Jennifer C. Paterson, Luca Malcovati, Matteo G. Della Porta, Martin Jädersten, Beena Pushkaran, Tracy I. George, Daniel A. Arber, Sally Killick, Aristoteles Giagou

Année:

2008

Langue:

english

Fichier:

PDF, 360 KB

english, 2008

Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes

Journal:

Année:

2009

Langue:

english

Fichier:

PDF, 242 KB

english, 2009

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome

Andrea Pellagatti, Mario Cazzola, Aristoteles Giagounidis, Janet Perry, Luca Malcovati, Matteo G. Della Porta, Martin Jädersten, Sally Killick, Paresh Vyas, Eva Hellström-Lindberg, James S. Wainscoat,

Journal:

M. Jädersten, E. Hellström-Lindberg

Année:

2011

Langue:

english

Fichier:

PDF, 77 KB

english, 2011

Myelodysplastic syndromes: biology and treatment

Journal:

Journal of Internal Medicine

Année:

2009

Langue:

english

Fichier:

PDF, 368 KB

english, 2009

Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome

Carlsten, M, Baumann, B C, Simonsson, M, Jädersten, M, Forsblom, A-M, Hammarstedt, C, Bryceson, Y T, Ljunggren, H-G, Hellström-Lindberg, E, Malmberg, K-J

Journal:

Leukemia

Année:

2010

Langue:

english

Fichier:

PDF, 733 KB

english, 2010

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells

Pellagatti, A, Cazzola, M, Giagounidis, A, Perry, J, Malcovati, L, Della Porta, M G, Jädersten, M, Killick, S, Verma, A, Norbury, C J

Journal:

Leukemia

Année:

2010

Langue:

english

Fichier:

PDF, 521 KB

english, 2010

New clues to the molecular pathogenesis of myelodysplastic syndromes

Martin Jädersten, Eva Hellström-Lindberg

Journal:

Experimental Cell Research

Année:

2010

Langue:

english

Fichier:

PDF, 576 KB

english, 2010

Identification of Gene Expression-Based Prognostic Markers in the Hematopoietic Stem Cells of Patients With Myelodysplastic Syndromes

Pellagatti, A., Benner, A., Mills, K. I., Cazzola, M., Giagounidis, A., Perry, J., Malcovati, L., Della Porta, M. G., Jadersten, M., Verma, A., McDonald, E.-J., Killick, S., Hellstrom-Lindberg, E., Bu

Journal:

Année:

2013

Langue:

english

Fichier:

PDF, 291 KB

english, 2013

I-017 Erythropoiesis stimulating agents in MDS

Jädersten, M.

Journal:

Année:

2013

Langue:

english

Fichier:

PDF, 80 KB

english, 2013

Erythropoietin and Granulocyte-Colony Stimulating Factor Treatment Associated With Improved Survival in Myelodysplastic Syndrome

Jadersten, M., Malcovati, L., Dybedal, I., Giovanni Della Porta, M., Invernizzi, R., Montgomery, S. M., Pascutto, C., Porwit, A., Cazzola, M., Hellstrom-Lindberg, E.

Journal:

Gerstung, Moritz, Pellagatti, Andrea, Malcovati, Luca, Giagounidis, Aristoteles, Porta, Matteo G Della, Jädersten, Martin, Dolatshad, Hamid, Verma, Amit, Cross, Nicholas C. P., Vyas, Paresh, Killick,

Année:

2008

Langue:

english

Fichier:

PDF, 142 KB

english, 2008

Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes

Journal:

Nature Communications

Année:

2015

Langue:

english

Fichier:

PDF, 1.64 MB

english, 2015

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients

Pellagatti, A., Jadersten, M., Forsblom, A.-M., Cattan, H., Christensson, B., Emanuelsson, E. K., Merup, M., Nilsson, L., Samuelsson, J., Sander, B., Wainscoat, J. S., Boultwood, J., Hellstrom-Lindber

Journal:

Proceedings of the National Academy of Sciences

Année:

2007

Langue:

english

Fichier:

PDF, 1.00 MB

english, 2007

TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression

Jadersten, M., Saft, L., Smith, A., Kulasekararaj, A., Pomplun, S., Gohring, G., Hedlund, A., Hast, R., Schlegelberger, B., Porwit, A., Hellstrom-Lindberg, E., Mufti, G. J.

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 747 KB

english, 2011

Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis

Koreth, J., Pidala, J., Perez, W. S., Deeg, H. J., Garcia-Manero, G., Malcovati, L., Cazzola, M., Park, S., Itzykson, R., Ades, L., Fenaux, P., Jadersten, M., Hellstrom-Lindberg, E., Gale, R. P., Beac

Journal:

Année:

2013

Langue:

english

Fichier:

PDF, 188 KB

english, 2013

307 DEVELOPMENT AND IMPLEMENTATION OF A NEW BIOBANK SYSTEM

Jansson, M., Walldin, G., Azenkoud, A. Ben, Dimitriou, M., Karimi, M., Tobiasson, M., Jädersten, M., Tapia, J., Lindberg, E. Hellström

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 111 KB

english, 2015

SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts

Malcovati, L., Karimi, M., Papaemmanuil, E., Ambaglio, I., Jadersten, M., Jansson, M., Elena, C., Galli, A., Walldin, G., Della Porta, M. G., Raaschou-Jensen, K., Travaglino, E., Kallenbach, K., Pietr

Journal:

Blood

Année:

2015

Langue:

english

Fichier:

PDF, 1.13 MB

english, 2015

Pathophysiology and treatment of the myelodysplastic syndrome with isolated 5q deletion

Jadersten, M.

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 1.54 MB

english, 2010

Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations

Scharenberg, Christian, Giai, Valentina, Pellagatti, Andrea, Saft, Leonie, Dimitriou, Marios, Jansson, Monika, Jädersten, Martin, Grandien, Alf, Douagi, Iyadh, Neuberg, Donna S., LeBlanc, Katarina, Bo

Journal:

Année:

2017

Langue:

english

Fichier:

PDF, 6.27 MB

english, 2017

Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities

Mollgard, L., Saft, L., Treppendahl, M. B., Dybedal, I., Norgaard, J. M., Astermark, J., Ejerblad, E., Garelius, H., Dufva, I. H., Jansson, M., Jadersten, M., Kjeldsen, L., Linder, O., Nilsson, L., Ve

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 692 KB

english, 2011

Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression

Jadersten, M., Saft, L., Pellagatti, A., Gohring, G., Wainscoat, J. S., Boultwood, J., Porwit, A., Schlegelberger, B., Hellstrom-Lindberg, E.

Journal:

Jadersten, M., Karsan, A.

Année:

2009

Langue:

english

Fichier:

PDF, 297 KB

english, 2009

Clonal evolution in myelodysplastic syndromes with isolated del(5q): the importance of genetic monitoring

Journal: